Dow converts natural-gas liquids and naphtha into polyethylene packaging resins, polyurethanes, industrial intermediates and silicones at 91 manufacturing sites.
Latest research: initiation, Nov 20, 2026 · Market value $22,091m
DOWBuyTarget $37.84+29% expected
Our view, Nov 20, 2026
Lasting cost cuts make Dow worth about $40, not today’s $30
Dow turns cheap US natural-gas liquids into plastics, foams and silicones, and is coming out of its worst trough in years. The market treats its cost cuts as temporary; we think about $0.9bn of them last.
Where the price could be in 12 months
Circle size shows how likely we think each case is. Case values are at the price date; the target weights all three and adds 12 months of expected return. Source: Penmark Research.
Our FY27E earnings forecast is 56% above analysts’
For FY26E we forecast earnings per share of $2.71, against analysts’ $2.58. For FY27E we forecast earnings per share of $2.87, against analysts’ $1.84.
Our earnings per share forecasts against analysts’
Our estimateAnalysts’ forecast
Earnings per share as the report gives them. Analysts’ forecast is the consensus figure in the report. Source: Penmark Research estimates.
The FY23 to FY25 overbuild becomes the new mid-cycle, capping margins at 11.0%: −$16.04 a share (40% probability).
Transform to Outperform savings are competed away, with 55% FY27E realisation and none kept at mid-cycle: −$6.61 a share.
Middle East de-escalation resets polyethylene spreads: −$1.29 a share; a one-point rise in WACC cuts the target by $10.91 to $26.93.
What bears get right. Chinese plants keep coming. If global plants stay stuck in the low 80s for good and margins settle at 11.0%, our value drops by about $16 a share.
Dates to watch
US polyethylene price rises of 7¢/lb and 5¢/lb settle. A full hold adds $0.86 a share.
Dow sets out its 2027 savings plan. We expect $1.1bn against the $1.3bn promised.
Talks with Saudi Aramco on the Sadara venture. Settling below book value adds $0.35 a share.
Progress at Böhlen and Schkopau. Extra global closures would add $2.13 a share.
We credit $867m of lasting mid-cycle EBITDA from Transform to Outperform and European closures, worth $8.05 a share that the price treats as near zero.
Our FY27E operating EBITDA of $6,434m is 16% above the $5,548m consensus and our $2.87 EPS 56% above $1.84, after a 4¢/lb polyethylene fade.
Path2Zero in Alberta adds $2.7bn of net present value, or $3.70 a share, with about 45% of the $7.5bn gross budget already built.
Penmark Research rates Dow (DOW) Buy, with a 12-month price target of $37.84, +25% from the $30.37 share price at our latest report. We expect a total return of more than 10% over the next 12 months: the move to our price target, plus dividends.
What is the DOW price target?
Our 12-month price target for Dow is $37.84, set in our initiation of Nov 20, 2026. Our bear case values the shares at $16.20 and our bull case at $50.92. The target comes from the probability-weighted value of our bull, base and bear cases.
Will Dow stock go up?
Our Dow stock forecast is a 12-month price target of $37.84, +25% from the $30.37 share price at our latest report, which is why we rate it Buy. Our bear case puts the shares at $16.20 (-47%) and our bull case at $50.92 (+68%). No forecast is certain; the main risks are below.
What does Dow do?
Dow converts natural-gas liquids and naphtha into polyethylene packaging resins, polyurethanes, industrial intermediates and silicones at 91 manufacturing sites.
What are the main risks to Dow stock?
The FY23 to FY25 overbuild becomes the new mid-cycle, capping margins at 11.0%: −$16.04 a share (40% probability).
Transform to Outperform savings are competed away, with 55% FY27E realisation and none kept at mid-cycle: −$6.61 a share.
Middle East de-escalation resets polyethylene spreads: −$1.29 a share; a one-point rise in WACC cuts the target by $10.91 to $26.93.
What is Penmark’s latest research on Dow?
Our latest report is our initiation of Nov 20, 2026, “Initiate at Buy with a $38 target as cost self-help cushions 2027 margins”. We initiate on Dow at Buy (low conviction) with a $37.84 target, a 29.2% total return from $30.37 including the $1.40 dividend. Retained cost self-help adds $8.05 a share and Path2Zero $3.70, while consensus FY27E operating EBITDA of $5.5bn and EPS of $1.84 sit 16% and 56% below our $6.4bn and $2.87. A one-point rise…